Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells.
about
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acidsLysophospholipid receptors LPA1–3 are not required for the inhibitory effects of LPA on mouse retinal growth conesMembrane-derived phospholipids control synaptic neurotransmission and plasticityLysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesMechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancerLipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradationAiming drug discovery at lysophosphatidic acid targets.A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.Neurobiology of lysophosphatidic acid signaling.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators.LPA in neural cell development.Genetics and cell biology of lysophosphatidic acid receptor-mediated signaling during cortical neurogenesis.A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.Lysophosphatidic acid induces neointima formation through PPARgamma activation.Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.GPR35 as a Novel Therapeutic Target.Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.Nucleoside-based phospholipids and their liposomes formed in water.Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis
P2860
Q24534268-3A299F56-E9AF-4FC7-B303-30D25C21379CQ27337671-FD4BC01C-3556-434E-9880-270B00E15FB4Q27347783-B3FFE977-3A2D-42E0-9A07-B70BFB8B8CBFQ30051813-8443A554-2040-434A-A3F6-A1A90D9089C9Q30410474-CEB2A385-9A2D-4BF1-8A43-F98A7A247ECDQ33538779-263DE2D1-CE5D-4C83-BC06-43876FF90A4CQ33825153-CD4D59E1-4DD5-4250-ADA2-B5A3E5CF5A5EQ34268347-D402A4CC-8EF7-4056-8E68-8C9F41F6F13DQ34300049-54E25F4B-500D-4FAC-8FDB-213F285463F6Q34339759-3D2B8810-BEE7-47DE-9A31-1264A6D2E094Q34575024-4FD85AD9-B2D9-4711-9ECC-BE525088754DQ35017623-C1E9694D-CF94-42D1-B1F9-09CCB03704D1Q35425244-5DAC8129-4284-4EC4-A52C-04F87634828FQ35598539-3C07235B-2C0F-4BF1-806D-97AE7364A22BQ35839006-9AFE7F3C-C530-49F6-BC17-543764C87E46Q35839037-45AF5222-1E56-465C-9295-EBBC488272CCQ35839041-2E9D06F0-4A29-4F94-9FA6-5E12D20784A3Q36063011-DE1845E8-D2B3-4620-A4E9-11A5076F942FQ36402330-85540988-0399-4D16-B8C7-8702BAA11B4DQ37375487-7451744A-137C-46DD-8196-9811C9F24ADDQ37428175-EA2D444D-4E95-44C7-AB1E-FCFCCD9CDA7BQ38012043-57658349-16B7-4545-836B-052415E49D18Q39269910-B70A0A94-1FED-4190-9DCE-51610AD51275Q39799967-E6B6633E-E81A-4A40-9E1F-52401478EB18Q39915747-5FF96633-C94F-4287-8B92-9A813587A7BBQ40195489-D66A0381-0F29-4C14-B035-04353C50FB86Q45242818-430ABB18-DDF7-4C35-9A1D-DAB3D659E326Q47191829-DED27EFF-69DD-4F38-8763-955E39AA23A4Q48159157-AFF7AA1E-6876-4333-BA60-E62F929156E0Q57067868-E4331366-7BA1-4B70-B082-6CD6BA22A57A
P2860
Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@en
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@nl
type
label
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@en
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@nl
prefLabel
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@en
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@nl
P2093
P1476
Occurrence of lysophosphatidic ...... toward cultured neural cells.
@en
P2093
A Tokumura
D J Hanahan
S Kishimoto
Y Yoshioka
P304
P356
10.1016/S1388-1981(99)00127-4
P577
1999-09-01T00:00:00Z